ResMed Inc. Financial Ratios — RMD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	22.72	20.55	20.86	20.56	18.78	17.04	15.29	13.29	16.62	23.59	16.05	23.29	22.82	22.08	25.3
Return on Assets (%)	12.29	12.12	14.13	15.1	15.54	12.96	10.18	9.66	11.28	14.3	10.19	15.87	15.15	14.99	18.62
Return on Capital (%)	20.57	18.27	17.86	17.69	16.41	12.88	10.86	10.89	13.48	16.73	12.17	18.98	18.06	18.08	21.89
Return on Invested Capital (%)	12.22	12.13	14.74	16.38	16.63	14.51	12.48	12.16	16.76	18.86	12.5	19.58	18.57	19.21	21.99
Gross Margin (%)	59.63	59.97	62.11	63.65	60.24	58	56.72	57.04	57.32	58.09	57.53	56.57	55.78	56.67	59.36
EBITDA Margin (%)	27.15	27.79	28.6	31.18	28.73	28.43	27.53	29.07	30.18	33.49	34.53	33.43	31.96	34.16	37.37
Operating Margin (%)	21.47	21.51	23.43	26.46	24.38	23.7	22.1	23.94	24.4	27.36	28.54	28.01	27.28	29.54	32.79
Incremental Operating Margin (%)	15.61	21.92	41.4	139.67	-1.76	16.66	9.15	37.86	28.43	49.39	43.07	23.55	23.24	50.21	65.78
Pretax Margin (%)	24.43	24.26	25.43	27.72	25.96	23.91	20.26	22.28	19.91	24.79	27.64	26.84	26.09	27	32.6
Profit Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Net Income to Common Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Effective Tax Rate (%)	25.26	23.23	20.25	19.9	19.05	19.83	18.26	39.46	22.02	15.2	46.3	18.85	18.53	19.28	16.5
Dvd Payout Ratio (%)	- -	- -	31.65	40.99	44.56	47.71	54.44	63.21	52.33	36.21	47.78	31.48	28.78	27.65	22.19
Sustainable Growth Rate (%)	22.72	20.55	14.26	12.13	10.41	8.91	6.97	4.89	7.92	15.05	8.38	15.96	16.25	15.98	19.68

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
ST Debt	- -	- -	300	- -	- -	299	- -	11	12	33	36	32	32	35	40
LT Debt	100	251	1	301	301	873	1,079	270	1,259	1,266	758	886	1,548	839	811
Total Debt/EBITDA	0.3	0.66	0.69	0.62	0.62	2.24	1.9	0.41	1.62	1.31	0.72	0.77	1.17	0.55	0.44
Net Debt/EBITDA	-1.88	-1.47	-1.33	-1.25	-0.86	0.84	0.45	0.14	1.43	0.72	0.33	0.42	0.9	0.29	-0.28
Total Debt/EBIT	0.38	0.85	0.85	0.73	0.73	2.69	2.36	0.5	2	1.61	0.87	0.92	1.37	0.63	0.5
Net Debt/EBIT	-2.38	-1.9	-1.62	-1.47	-1.02	1.01	0.56	0.17	1.77	0.88	0.39	0.5	1.05	0.34	-0.32
EBITDA to Interest Expense	192	79.45	67.81	79.11	83.47	46.65	20.15	23.99	21.76	24.53	46.02	53.6	28.48	35.01	- -
EBITDA-CapEx/Interest Expense	150.46	66.69	56.57	65.87	71.02	40.59	17.62	21.47	19.62	21.91	41.15	46.61	25.66	32.5	- -
EBIT to Interest Expense	151.83	61.51	55.55	67.13	70.83	38.9	16.18	19.76	17.59	20.04	38.03	44.92	24.31	30.28	- -
Interest Expense	2	5	6	6	6	11	28	28	36	40	24	22	47	46	- -
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
Net Debt to Equity	-36.7	-34.75	-35.72	-34.41	-26.25	26.04	13.09	4.5	54.23	28.55	12.48	14.92	29.38	9.64	-9.07
Net Debt/Capital (%)	-133.04	-69.1	-57.41	-51.44	-26.71	16.96	9.97	3.67	31.56	19.43	10.06	11.78	21.64	8.33	-9.45
EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
EBITDA-CapEx	264	319	361	404	410	455	497	609	709	884	987	1,040	1,216	1,485	1,823
Operating Income (Loss)	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.52	3.2	1.53	3.36	2.69	1.15	2.28	0.37	0.26	0.77	0.32	0.4	0.3	0.26	1.19
Current Ratio	6.19	5.38	2.52	5.77	5.28	2.23	4.57	2.08	2.06	2.53	1.73	2.8	3.12	2.59	3.44
Quick Ratio	4.88	4.33	2.1	4.69	4.05	1.75	3.53	1.32	1.22	1.56	1	1.23	1.23	1.22	2.16
CFO/Avg Current Liab	1.09	1.66	0.97	0.93	1.43	1.21	0.83	1.16	0.86	1.38	0.97	0.44	0.96	1.68	1.82
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
CFO/Total Liabilities	83.74	72.26	67.11	64.92	64.46	35.08	27.45	50.25	22.55	38.38	39.99	20.24	26.44	69.77	79.38
CFO/CapEx	3.88	6.27	5.61	4.82	5.33	8.08	5.79	7.07	5.94	7.57	6.31	2.25	5.17	12.2	17.4
Altman's Z-Score	11.16	8.21	9.6	10.56	11.82	7.22	8.28	13.47	10.25	12.71	16.37	15.36	11.98	13.48	4.76

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	4.96	4.91	5.04	4.59	4.65	4.94	4.96	5.01	5.15	5.9	5.87	6.01	6.59	6.08	5.79
Days Sales Outstanding	73.59	74.35	72.48	79.57	78.5	73.91	73.52	72.85	70.87	61.91	62.17	60.71	55.35	60.07	63.01
Inventory Turnover	2.6	2.92	3.58	3.63	3.24	3.28	3.63	3.74	3.6	3.23	3.11	2.59	2.14	2.23	2.39
Days Inventory Outstanding	140.53	124.98	101.84	100.51	112.72	111.39	100.54	97.49	101.44	112.89	117.47	141.05	170.24	163.64	152.71
Accounts Payable Turnover	9.17	9.46	9.43	8.01	9	8.63	10.13	10.84	11.45	10.39	10.21	12.38	13.69	9.55	8.52
Accounts Payable Turnover Days	39.8	38.58	38.72	45.59	40.58	42.27	36.05	33.66	31.88	35.13	35.75	29.47	26.67	38.24	42.86
Cash Conversion Cycle	174.32	160.75	135.61	134.48	150.64	143.02	138.02	136.68	140.43	139.67	143.89	172.29	198.93	185.48	172.86
Inventory to Cash Days	-66.94	-50.63	-29.36	-20.94	-34.22	-37.48	-27.02	-24.64	-30.57	-50.98	-55.31	-80.35	-114.89	-103.57	-89.7
Inventories	201	174	146	165	247	224	268	269	350	417	457	744	998	822	928
Raw Materials	74	66	47	54	74	67	76	75	81	128	155	355	459	356	367
Work In Process	4	2	2	3	3	4	4	2	2	3	5	3	4	3	3
Finished Goods	123	107	97	108	170	153	188	191	267	286	297	386	535	464	558
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	4,719	4,552	6,452	7,163	7,918	8,868	11,008	14,787	17,464	27,713	35,823	30,620	32,068	28,143	- -
- Cash & Cash Equivalents	735	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
Enterprise Value	4,084	3,993	5,876	6,558	7,502	9,309	11,264	14,880	18,588	28,549	36,321	31,264	33,420	28,778	-358
Total Capital	1,213	1,618	1,878	2,082	2,277	3,334	3,395	2,714	3,708	4,133	3,874	4,532	5,834	5,866	6,934
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt / EV	0.02	0.06	0.05	0.05	0.04	0.13	0.1	0.02	0.07	0.05	0.02	0.03	0.05	0.03	-2.38
EV/Sales	3.29	2.92	3.88	4.22	4.47	5.06	5.45	6.36	7.13	9.65	11.36	8.74	7.91	6.14	- -
EV/EBITDA	12.1	10.5	13.57	13.53	15.55	17.81	19.8	21.88	23.62	28.82	32.9	26.14	24.76	17.98	- -
EV/EBIT	15.3	13.56	16.56	15.94	18.33	21.36	24.66	26.56	29.23	35.29	39.81	31.2	29.01	20.79	- -
EV/Cash Flow to Firm	14.35	10.32	14.41	16.55	19.34	16.71	25.77	28.5	38.15	34.13	48.45	84.67	45.66	20.01	- -
EV/Free Cash Flow to Firm	11.42	8.92	12.25	13.74	16.31	14.9	22.15	25.07	32.92	30.29	41.92	59.52	38.6	18.53	- -
Diluted Market Cap	4,865	4,659	6,607	7,309	8,043	8,958	11,093	14,914	17,631	27,965	36,103	30,825	32,219	28,244	- -
Diluted Enterprise Value	4,230	4,100	6,032	6,704	7,627	9,399	11,349	15,007	18,755	28,801	36,602	31,468	33,571	28,880	-358
EV per Share	26.78	27.37	41.11	46.35	53.4	66.38	79.69	104.23	129.88	197.79	249.95	214.04	227.71	195.74	- -
TTM Sales	1,243	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146
TTM EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
TTM Operating Income	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687
TTM Cash Flow to Firm	285	387	408	396	388	557	437	522	487	836	750	369	732	1,438	1,752
TTM Free Cash Flow to Firm	358	448	480	477	460	625	509	594	565	942	866	525	866	1,553	1,852

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	13.66	10.49	13.92	15.47	17.67	14.55	22.85	25.87	32.87	30.79	42.3	60.78	38.94	18.63	- -
EV/EBIT	15.3	13.56	16.56	15.94	18.33	21.36	24.66	26.56	29.23	35.29	39.81	31.2	29.01	20.79	- -
Enterprise Value	4,084	3,993	5,876	6,558	7,502	9,309	11,264	14,880	18,588	28,549	36,321	31,264	33,420	28,778	-358
Low Price	29.24	23.37	30.39	41.52	45.74	48.99	56.59	71.29	90.64	108.85	165.72	189.4	202.04	132.24	186.22
EV/Sales	3.29	2.92	3.88	4.22	4.47	5.06	5.45	6.36	7.13	9.65	11.36	8.74	7.91	6.14	- -
EV/EBITDA	12.1	10.5	13.57	13.53	15.55	17.81	19.8	21.88	23.62	28.82	32.9	26.14	24.76	17.98	- -
Price/Earnings	20.79	17.86	21.01	20.75	22.44	25.16	32.16	46.86	43.16	44.58	75.49	39.28	35.73	27.57	- -
Price/Earnings Average	21.6	16.86	19.56	19.85	22.97	22.46	27.71	40.13	38.1	34.68	60.83	46.33	36.27	25.94	- -
Price/Earnings High	24.11	20.22	23.92	23.49	29.99	25.52	32.81	48.99	43.62	44.86	75.88	56.47	40.49	33.12	- -
Price/Earnings Low	19.64	13.38	14.14	17.01	18.21	19.5	23.37	32.25	32.06	25.27	50.75	35.49	33.04	19.04	- -
Price/Book Value	4.24	3.33	4.09	4.02	4.01	4.1	4.75	6.08	7.17	9.78	11.63	8.47	7.54	5.64	- -
Price/Book Value Average	4.41	3.14	3.81	3.85	4.1	3.66	4.09	5.21	6.32	7.61	9.37	9.99	7.65	5.3	- -
Price/Book Value High	4.92	3.77	4.66	4.55	5.35	4.16	4.85	6.35	7.24	9.84	11.69	12.18	8.54	6.77	- -
Price/Book Value Low	4.01	2.49	2.75	3.3	3.25	3.18	3.45	4.18	5.32	5.54	7.82	7.65	6.97	3.89	- -
Price/Tangible Book Value	3.26	3.51	5.02	5.03	6.21	26.41	17.37	19.08	-57.03	174.81	63.38	28.39	39.72	18.32	- -
Price/Tangible Book Value Average	3.39	3.31	4.67	4.81	6.35	23.57	14.97	16.34	-50.34	136	51.07	33.49	40.33	17.24	- -
Price/Tangible Book Value High	3.78	3.97	5.71	5.7	8.29	26.78	17.72	19.95	-57.64	175.9	63.71	40.82	45.02	22.01	- -
Price/Tangible Book Value Low	3.08	2.63	3.38	4.13	5.04	20.46	12.63	13.13	-42.36	99.1	42.61	25.65	36.73	12.66	- -
Price/Sales	3.8	3.33	4.26	4.61	4.72	4.82	5.33	6.32	6.7	9.37	11.21	8.56	7.59	6.01	- -
Price/Sales Average	3.94	3.14	3.97	4.41	4.83	4.3	4.59	5.41	5.91	7.29	9.03	10.09	7.71	5.65	- -
Price/Sales High	4.4	3.77	4.85	5.22	6.3	4.89	5.43	6.61	6.77	9.43	11.26	12.3	8.61	7.22	- -
Price/Sales Low	3.59	2.49	2.87	3.78	3.83	3.74	3.87	4.35	4.98	5.31	7.53	7.73	7.02	4.15	- -
Price/Cash Flow	16.66	11.88	16.02	18.31	20.66	16.18	26.59	29.28	38.04	34.54	48.62	87.2	46.25	20.08	- -
Price/Cash Flow Average	17.31	11.22	14.91	17.51	21.15	14.44	22.91	25.07	33.58	26.87	39.18	102.84	46.96	18.9	- -
Price/Cash Flow High	19.33	13.45	18.24	20.73	27.61	16.41	27.12	30.61	38.45	34.76	48.88	125.35	52.43	24.13	- -
Price/Cash Flow Low	15.74	8.9	10.78	15.01	16.77	12.54	19.32	20.15	28.26	19.58	32.69	78.78	42.77	13.87	- -
Price/Free Cash Flow Average	14.19	9.9	12.96	14.8	18.09	12.98	19.69	22.15	29.01	23.96	34.08	71.68	39.54	17.53	- -
Price/Free Cash Flow High	15.84	11.87	15.86	17.52	23.62	14.75	23.31	27.05	33.22	30.98	42.52	87.36	44.14	22.38	- -
Price/Free Cash Flow Low	12.9	7.85	9.37	12.69	14.34	11.27	16.6	17.81	24.41	17.46	28.43	54.91	36.01	12.87	- -
EV/Sales Average	3.43	2.73	3.59	4.02	4.58	4.54	4.71	5.45	6.34	7.57	9.18	10.27	8.03	5.79	- -
EV/Sales High	3.89	3.36	4.47	4.83	6.05	5.13	5.56	6.65	7.2	9.71	11.42	12.48	8.93	7.35	- -
EV/Sales Low	3.08	2.08	2.49	3.39	3.58	3.98	3.99	4.39	5.41	5.6	7.69	7.91	7.34	4.29	- -
EV/EBITDA Average	12.64	9.83	12.54	12.89	15.94	15.99	17.13	18.75	21.02	22.61	26.6	30.73	25.13	16.95	-0.19
EV/EBITDA High	14.33	12.08	15.64	15.48	21.08	18.05	20.19	22.86	23.86	29	33.07	37.34	27.93	21.52	-0.19
EV/EBITDA Low	11.33	7.5	8.7	10.87	12.46	13.99	14.51	15.1	17.92	16.71	22.27	23.67	22.97	12.55	-0.19
EV/EBIT Average	15.99	12.7	15.31	15.19	18.79	19.17	21.33	22.77	26	27.68	32.18	36.68	29.43	19.59	-0.21
EV/EBIT High	18.13	15.61	19.09	18.25	24.84	21.64	25.15	27.76	29.52	35.5	40.01	44.56	32.72	24.89	-0.21
EV/EBIT Low	14.32	9.68	10.62	12.81	14.68	16.78	18.08	18.33	22.16	20.45	26.94	28.25	26.91	14.51	-0.21
Last Price	30.95	31.2	45.13	50.63	56.37	63.23	77.87	103.58	122.03	192	246.52	209.63	218.5	191.42	258
High Price	35.9	35.32	51.4	57.34	75.33	64.12	79.44	108.29	123.33	193.2	247.79	301.34	247.65	229.97	263.05
Enterprise Value Average	4,267	3,739	5,432	6,248	7,688	8,356	9,743	12,756	16,537	22,397	29,363	36,757	33,908	27,118	-358
Enterprise Value High	4,839	4,595	6,773	7,507	10,165	9,434	11,486	15,553	18,774	28,722	36,506	44,659	37,698	34,446	-358
Enterprise Value Low	3,823	2,851	3,769	5,269	6,008	7,312	8,256	10,270	14,095	16,547	24,580	28,309	31,004	20,078	-358

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	152	142	142	140	140	141	142	143	144	145	146	146	147	147	146
Diluted Weighted Avg Shares	157	149	146	144	143	142	142	144	144	146	146	147	147	148	- -
Basic Weighted Avg Shares	152	146	143	141	140	140	141	143	143	144	145	146	147	147	- -
Revenue per Share	8.15	9.38	10.59	10.99	11.95	13.11	14.62	16.39	18.21	20.49	22	24.5	28.77	31.87	- -
EBITDA per Share	2.21	2.61	3.03	3.43	3.43	3.73	4.02	4.76	5.5	6.86	7.6	8.19	9.2	10.89	- -
Operating Income per Share	1.75	2.02	2.48	2.91	2.91	3.11	3.23	3.92	4.44	5.61	6.28	6.86	7.85	9.41	- -
Basic EPS, GAAP	1.49	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94	- -
Basic EPS from Cont Ops	1.49	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94	- -
Diluted EPS, GAAP	1.44	1.71	2.1	2.39	2.47	2.49	2.4	2.19	2.8	4.27	3.24	5.3	6.09	6.92	- -
Diluted EPS from Cont Ops	1.44	1.71	2.1	2.39	2.47	2.49	2.4	2.19	2.8	4.27	3.24	5.3	6.09	6.92	- -
Dividend per Share	- -	- -	0.68	1	1.12	1.2	1.32	1.4	1.48	1.56	1.56	1.68	1.76	1.92	- -
Cash Flow per Share	1.86	2.63	2.82	2.77	2.73	3.91	2.93	3.54	3.21	5.56	5.07	2.4	4.72	9.53	- -
Free Cash Flow per Basic Share	1.38	2.21	2.32	2.19	2.22	3.42	2.42	3.04	2.67	4.82	4.27	1.34	3.81	8.75	- -
Cash & Equivalents per Share	4.82	5.55	6.13	6.4	5.11	5.22	5.81	1.32	1.03	3.21	2.03	1.87	1.55	1.62	- -
Book Value per Share	7.3	9.37	11.03	12.59	14.07	15.41	16.39	17.04	17.03	19.63	21.2	24.74	28.98	33.96	- -
Tangible Book Value per Share	9.49	8.89	9	10.06	9.08	2.39	4.48	5.43	-2.14	1.1	3.89	7.38	5.5	10.45	- -

ResMed Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)